Catalyst Funds Management Pty LTD Abb Vie Inc. Transaction History
Catalyst Funds Management Pty LTD
- $382 Billion
- Q1 2025
A detailed history of Catalyst Funds Management Pty LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 6,300 shares of ABBV stock, worth $1.16 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
6,300
Previous 1,200
425.0%
Holding current value
$1.16 Million
Previous $213 Million
519.01%
% of portfolio
0.35%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding ABBV
# of Institutions
4,255Shares Held
1.27BCall Options Held
18.2MPut Options Held
15.5M-
Vanguard Group Inc Valley Forge, PA174MShares$32 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$25.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$14.7 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.1 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$7.57 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $325B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...